The Rottweiler is a sturdy, powerful dog breed famed for its loyalty, protective instincts, and sharp intelligence. Widely employed as guard dogs and in security roles, these well-built dogs are recognized for their strong work ethic and responsive nature. Contrary to some media portrayals, Rottweilers are loving family companions with dependable temperaments.
Like many purebred dogs, Rottweilers inherit particular health issues passed down through generations. In the U.S., responsible breeders prioritize comprehensive genetic screening to detect and minimize hereditary health risks. Among these, leukoencephalomyelopathy, commonly called LEMP, is a significant neurological disorder impacting this breed.
LEMP is a hereditary, progressive neurological disease affecting the white matter in a dog's central nervous system. Typically emerging in young dogs aged 1 to 3 years, it gradually worsens over several months. Symptoms often include unsteady walking, dragging or knuckling of paws, and reduced mobility, which deeply affects the dog’s day-to-day life.
This condition stems from a genetic mutation in the NAPEPLD gene, essential for maintaining the myelin sheath that protects nerve fibers. Specifically, Rottweilers possess a unique insertion mutation (c.345_346insC) responsible for LEMP. Affected dogs inherit two copies of this mutation, while carriers possess one copy without showing symptoms but can transmit the mutation to their pups.
LEMP follows an autosomal recessive inheritance pattern. This means a puppy must receive one mutated gene from each parent to develop the disease. Understanding the genetic status of breeding dogs is vital to prevent breeding affected puppies.
DNA testing is crucial for making informed breeding decisions. Veterinarians in the U.S. collect DNA samples via blood or cheek swabs and send them to accredited labs. Test results categorize dogs as:
While the American Kennel Club (AKC) supports genetic health testing, dedicated official programs for LEMP in Rottweilers are evolving. Test results typically take 1-2 weeks, enabling timely breeder and owner decisions.
There is no current effective treatment for LEMP, so management focuses on maintaining quality of life. Early detection through DNA testing helps breeders avoid mating two carriers or affected dogs, significantly lowering affected puppy cases.
U.S. breeders who responsibly screen for LEMP and other hereditary diseases emphasize DNA testing before breeding to protect Rottweiler populations. If you own or plan to breed a Rottweiler, discussing DNA testing with your veterinarian is a compassionate step toward your dog’s health.
Besides LEMP, American Rottweilers may face several inherited health challenges including juvenile laryngeal paralysis and polyneuropathy (JLPP), a recessive disorder affecting breathing and swallowing, progressive retinal atrophy (PRA) impacting vision, and hereditary footpad hyperkeratosis causing skin problems. Comprehensive DNA panels offered by labs like Embark and others help identify these conditions.
Responsible breeding in the U.S. prioritizes such genetic screenings to prevent passing on deleterious mutations, ensuring healthier future litters. For example, avoiding carrier-to-carrier breeding radically decreases the risk of affected offspring with LEMP or JLPP.
Leukoencephalomyelopathy (LEMP) is a serious hereditary neurological disease in Rottweilers that compromises their mobility and well-being. In the U.S., employing DNA health testing is vital for recognizing carriers and affected dogs, enabling breeders to make responsible pairing choices. Along with routine genetic screening for other inherited issues, this approach helps safeguard the health of Rottweilers across the country and supports ethical breeding practices. By embracing these measures, American Rottweiler owners and breeders can promote longevity and a better quality of life for these remarkable dogs.